1Smitb C, Birmbaum G, Carter JL, Greenstein J, Lublin FD, US Tizamdine Scudy Group, Tizanidine trcaunent of spasticity caused by multiple sclerosis, Neurology 1994;44(Suppl 9);S34-43.
2The United Kijlgdom Tizanldine Trlal Group. A doublc-bbnd. Placebo-conetrolled trial of tizanichne in the treatment of spasticity caused by muluple sclerosis. Neurology 1994:44(Suppl 9):S70-8.
3Wallace JD. Surnmry of combiued clinacal analysis of coturollel clinical trials with tizaridine. Neurology,1994;44(Suppl 9):560-9.
4Mathias CJ.Luckier J. Desai P, Baker H.Maso WE Frankel HL.Pharmacodynamics and pharmacokinetics of the and anospastic agent tizamdine in patients with spinal cord injury J Rehabl Res Dev 1989;26:9-16.
5Nance J. Bugaresn J. Shellenberger K, Sheremata W, Martinez-Anizala A. North American Tizanidme Study Group. EfFicacy., and safety of tizanidine in the treatment of spasticity, in pauents with spina1 cord injury, Neurology 1994;14(Suppl 9):S44-52.
6Medici M. Pebet M, Ciblis D A double-bhnd,long-term study. of tizanidine (Sirdalud)in spasticlty due to cerebrmvascular lestons .Curr Med Res Opin 1989;11:398-407.
7Bes A.Eyssette M.Pterrot-Deseillgny E.et al.A.multi-centre.double-blind trial of tizanidine a new antispasticity agent in spasticity associated with hemiplegia Curr Mcd Res Opin 1988:10:7199-18.
8Pedersen E.Clinical.assessment and pharmacologic therapy of spastcity Arch Phys Med R ehahal 1974;55:344-54.
9Nance PW.Shears AH. Nance DM Rcflex changes induced hy clomdine in spinal cord injured patient, Paraplegia 1989:27:296-301.
10Donovan WH, Carter RE, Rossi CD. Wilkerson MA Clonidine effect on spasticily: A clinical real Arch Phys Med Rchabil 1988;69:193-4.
